Editorial: Pathogenetic mechanism and therapeutic target for inflammation in autoimmune disease.
作者信息
Li Jia, Liang Minrui, Pan Hai-Feng, Gao Jian, Lu Liangjing
机构信息
Department of Rheumatology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Department of Rheumatology, Huashan Hospital, Fudan University, Shanghai, China.
出版信息
Front Immunol. 2024 Mar 7;15:1385936. doi: 10.3389/fimmu.2024.1385936. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Pathogenetic mechanism and therapeutic target for inflammation in autoimmune disease.社论：自身免疫性疾病中炎症的发病机制及治疗靶点
Front Immunol. 2024 Mar 7;15:1385936. doi: 10.3389/fimmu.2024.1385936. eCollection 2024.
2
Editorial: innovative therapeutic approaches for the treatment of pediatric autoimmune and inflammatory diseases.
Curr Pharm Des. 2012;18(35):5728. doi: 10.2174/138161212803530790.
3
Therapeutic potential of interleukin-17 in inflammation and autoimmune diseases.白细胞介素-17 在炎症和自身免疫性疾病中的治疗潜力。
Expert Opin Ther Targets. 2014 Jan;18(1):29-41. doi: 10.1517/14728222.2013.843669. Epub 2013 Oct 23.
4
Immunosuppression with biologicals: prospects for the treatment of autoimmune diseases.
Expert Opin Biol Ther. 2002 Oct;2(7):687-91. doi: 10.1517/14712598.2.7.687.
5
Autoimmune diseases are connected with disturbances in cytokine synthesis, and therapy with IFN-gamma blockers is their main pathogenetic treatment.自身免疫性疾病与细胞因子合成紊乱有关，使用γ-干扰素阻滞剂进行治疗是其主要的病因治疗方法。
Ann N Y Acad Sci. 2007 Aug;1109:167-77. doi: 10.1196/annals.1398.020.
6
[Keratitis - Infectious or Autoimmune?].
Klin Monbl Augenheilkd. 2016 Jul;233(7):808-12. doi: 10.1055/s-0042-105155. Epub 2016 Jul 28.
7
[Trends in adjuvant pathogenetic therapy of infectious and autoimmune diseases].[感染性疾病和自身免疫性疾病辅助发病机制治疗的趋势]
Antibiot Khimioter. 2000;45(12):17-22.
8
Cardio-Rheumatology: Cardiovascular Complications in Systemic Autoimmune Rheumatic Diseases / Is Inflammation the Common Link and Target?心脏风湿病学：系统性自身免疫性风湿病中的心血管并发症/炎症是共同的联系和靶点吗？
Curr Vasc Pharmacol. 2020;18(5):425-430. doi: 10.2174/1570161118666200514222236.
9
Therapeutic Potential of Galectin-1 and Galectin-3 in Autoimmune Diseases.半乳糖凝集素-1 和半乳糖凝集素-3 在自身免疫性疾病中的治疗潜力。
Curr Pharm Des. 2022;28(1):36-45. doi: 10.2174/1381612827666210927164935.
10
Interleukin-13: A promising therapeutic target for autoimmune disease.白细胞介素-13：自身免疫性疾病有前途的治疗靶点。
Cytokine Growth Factor Rev. 2019 Feb;45:9-23. doi: 10.1016/j.cytogfr.2018.12.001. Epub 2018 Dec 12.
引用本文的文献
1
The role of hypoxic microenvironment in autoimmune diseases.缺氧微环境在自身免疫性疾病中的作用。
Front Immunol. 2024 Nov 7;15:1435306. doi: 10.3389/fimmu.2024.1435306. eCollection 2024.
2
Navigating the Neuroimmunomodulation Frontier: Pioneering Approaches and Promising Horizons-A Comprehensive Review.神经免疫调节前沿探索：开拓性方法与广阔前景——全面综述。
Int J Mol Sci. 2024 Sep 7;25(17):9695. doi: 10.3390/ijms25179695.
本文引用的文献
1
Proposals for the rheumatological use of JAK inhibitors.关于JAK抑制剂在风湿病学领域应用的建议。
Nat Rev Rheumatol. 2024 Feb;20(2):65-66. doi: 10.1038/s41584-023-01068-3.
2
The rise of precision cellular therapies.
Nat Rev Rheumatol. 2024 Feb;20(2):69-70. doi: 10.1038/s41584-023-01073-6.
3
Exploring the latest advances in axial spondyloarthritis management.
Nat Rev Rheumatol. 2024 Feb;20(2):79-80. doi: 10.1038/s41584-023-01072-7.
4
The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS).2022 年 EULAR/ACR 在疑似噬血细胞性淋巴组织细胞增生症/巨噬细胞活化综合征（HLH/MAS）的早期诊断和管理中需要考虑的要点。
Ann Rheum Dis. 2023 Oct;82(10):1271-1285. doi: 10.1136/ard-2023-224123. Epub 2023 Jul 24.
5
Trained immunity and inflammation in rheumatic diseases.训练免疫与风湿性疾病中的炎症反应
Joint Bone Spine. 2022 Jul;89(4):105364. doi: 10.1016/j.jbspin.2022.105364. Epub 2022 Feb 24.
6
NF-κB: At the Borders of Autoimmunity and Inflammation.NF-κB：自身免疫和炎症的交界处。
Front Immunol. 2021 Aug 9;12:716469. doi: 10.3389/fimmu.2021.716469. eCollection 2021.
7
Kinase inhibition in autoimmunity and inflammation.激酶抑制在自身免疫和炎症中的作用。
Nat Rev Drug Discov. 2021 Jan;20(1):39-63. doi: 10.1038/s41573-020-0082-8. Epub 2020 Oct 19.
8
Immune-mediated Pathogenesis and Therapies for Inflammatory Autoimmune Diseases.
Curr Pharm Des. 2019;25(27):2907-2908. doi: 10.2174/138161282527191007151037.
9
Human autoimmune diseases: a comprehensive update.人类自身免疫性疾病：全面更新。
J Intern Med. 2015 Oct;278(4):369-95. doi: 10.1111/joim.12395. Epub 2015 Jul 25.
Zotero 插件